How much is Rallybio worth in 2026?

Rallybio has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has Rallybio raised?

Rallybio has raised N/A in total funding across 1 funding rounds.

Rallybio

Drug Discovery

Rallybio valuation and funding history | Last updated: May 19, 2020 | 1 funding rounds

Current Valuation

N/A

As of May 19, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series B)

$145.0M

Last Funding

May 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 19, 2020	Early Stage VC (Series B)	$145.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Rallybio is currently valued at N/A as of May 19, 2020.

Track Rallybio Valuation Updates

Get notified when Rallybio raises new funding or valuation changes

Explore More Data

Detailed analysis for Rallybio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Rallybio's valuation history, funding rounds, and growth metrics.

No credit card required

What is Rallybio Worth in 2026?

Rallybio is a leading private company in the Drug Discovery sector. Track Rallybio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Rallybio Valuation is Determined

Private company valuations like Rallybio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.